
[Federal Register Volume 76, Number 42 (Thursday, March 3, 2011)]
[Notices]
[Page 11789]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4739]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2006-N-0238] (formerly 2006N-0062)


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Expanded Access to Investigational 
Drugs for Treatment Use

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Expanded Access to Investigational 
Drugs for Treatment Use'' has been approved by the Office of Management 
and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Elizabeth Berbakos, Office of 
Information Management, Food and Drug Administration, 1350 Piccard Dr., 
PI50-400B, Rockville, MD 20850, 301-796-3792, 
Elizabeth.Berbakos@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In the Federal Register of December 14, 2006 
(71 FR 75147), the Agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0653. 
The approval expires on December 31, 2011. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://www.reginfo.gov/public/do/PRAMain.

    Dated: February 23, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-4739 Filed 3-2-11; 8:45 am]
BILLING CODE 4160-01-P


